The control and intervention groups were similar in sex distribution, underlying hematological disease, history of fungal infections, presence of central catheter, granulocyte colony-stimulating factor usage, minimum albumin levels, and severity of neutropenia (Table 1). The gene discussed is CSF3; the disease is fungal infectious disease.